Journal of the Neurological Sciences
Volume 205, Issue 1 , Pages 21-27 , 15 December 2002

Acetazolamide challenge test using semiquantitative 123I-IMP SPECT for detection of cerebral misery perfusion

  • Shigeru Fujimoto

      Affiliations

    • Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
    • ,
  • Yasuhiro Hasegawa

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +81-6-6833-5012; fax: +81-6-6872-7486
    • Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
    • ,
  • Chiaki Yokota

      Affiliations

    • Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
    • ,
  • Masafumi Tagaya

      Affiliations

    • Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
    • ,
  • Kohei Hayashida

      Affiliations

    • Department of Diagnostic Radiology, National Cardiovascular Center, Osaka, Japan
    • ,
  • Takenori Yamaguchi

      Affiliations

    • Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
    • ,
  • Kazuo Minematsu

      Affiliations

    • Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan

Received 19 March 2002 ,Revised 10 July 2002 ,Accepted 15 July 2002.

References 

  1. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann. Neurol. 1991;29:231–240
  2. National Institute of Neurological Disorders and Stroke Ad Hoc Committee . Classification of cerebrovascular disease: III. Stroke. 1990;21:637–676
  3. Grubb RL, Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, et al.  Importance of hemodynamic factors in prognosis of symptomatic carotid occlusion. JAMA. 1998;280:1055.d–1060.d
  4. Derdeyn CP, Videen TO, Fritsch SM, Carpenter DA, Grubb RL, Powers WJ. Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion. Stroke. 1999;30:1019–1024
  5. Hirano T, Minematsu K, Hasegawa Y, Tanaka Y, Hayashida K, Yamaguchi T. Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters. J. Cereb. Blood Flow Metab. 1994;14:763–770
  6. Yokota C, Hasegawa Y, Minematsu K, Yamaguchi T. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive disease. Stroke. 1998;29:640–644
  7. Hasegawa Y, Yamaguchi T, Tsuchiya T, Minematsu K, Nishimura T. Sequential change of hemodynamic reserve in patients with major cerebral artery occlusion or severe stenosis. Neuroradiology. 1992;34:15–21
  8. Cao B, Hasegawa Y, Yokota C, Minematsu K, Yamaguchi T. Spontaneous improvement in reduced vasodilatory capacity in major cerebral arterial occlusive disease. Neuroradiology. 2000;42:19–25
  9. Widder B, Kleiser B, Krapf H. Course of cerebrovascular reactivity in patients with carotid artery occlusion. Stroke. 1994;25:1963–1967
  10. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J. Neurosurg. 1993;79:483–489
  11. Yonas H, Pindzola RR, Meltzer CC, Sasser HS. Qualitative versus quantitative assessment of cerebrovascular reserves. Neurosurgery. 1998;42:1005–1012
  12. Webster MW, Makaroun MS, Steed DL, Smith HA, Yonas H. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J. Vasc. Surg. 1995;21:338–345
  13. Frackowiak RSJ, Lenzi GL, Jones T, Heather JD. Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J. Comput. Assist. Tomogr. 1980;4:727–736
  14. Lammertsma AA, Jones T, Frackowiak RSJ, Lenzi GL. A theoretical study of the steady-state model for measuring regional cerebral blood flow and oxygen utilization using oxygen-15. J. Comput. Assist. Tomogr. 1981;5:544–550
  15. Martin WRW, Powers WJ, Raichle ME. Cerebral blood volume measured with inhaled C15O and positron emission tomography. J. Cereb. Blood Flow Metab. 1987;7:421–426
  16. Lammertsma AA, Baron J-C, Jones T. Correction for intravascular activity in the oxygen-15 steady-state technique is independent of the regional hematocrit. J. Cereb. Blood Flow Metab. 1987;7:372–374
  17. Yamaguchi T, Kanno I, Uemura K, Shishido F, Inugami A, Ogawa T, et al.  Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke. 1986;17:1220–1228
  18. Fujii K, Sadoshima S, Okada Y, Yao H, Kuwabara Y, Ichiya Y, et al.  Cerebral blood flow and metabolism in normotensive and hypertensive patients with transient neurologic deficits. Stroke. 1990;21:283–290
  19. Hasegawa Y, Minematsu K, Matsuoka H, Imamura T, Tanaka Y, Hayashida K, et al.  CBF responses to acetazolamide and CO2 for the prediction of hemodynamic failure: a PET study. Stroke. 1997;28:242; [Abstract]

PII: S0022-510X(02)00244-7

Journal of the Neurological Sciences
Volume 205, Issue 1 , Pages 21-27 , 15 December 2002

Article Tools

* Image Usage & Resolution